Complex Regional Pain Syndrome Type I of the Upper Limb
Conditions
Brief summary
Background of the study: CRPS type-1 is a pain syndrome that usually develops after an initiating noxious event (e.g. fracture) in an extremity. Although treatment options life dimethyl-sulphoxide (DMSO), N-acetylcysteine (NAC) and intensive physical therapy exist, the treatment effect is often unsatisfactory, even leading to amputation of the extremity. Surgical treatment of chronic pain disorders by dividing the sympathetic chain is an established treatment. Its more invasive nature has prevented widespread application. After introduction of minimal invasive techniques in recent years, the UMCG has now devised a truly minimal invasive, yet safe and effective thoracoscopic technique, that requires only a single 1 cm long incision in the anterior axillary line. This technique is developed as treatment for primary focal axillary and palmar hyperhidrosis, and is performed in over 50 patients producing very satisfying results. This fact has led to the hypothesis that this same surgical technique can offer this group of chronic pain patients a safe, effective treatment modality. Objective of the study: The effect of the intervention on pain an regain of function in de affected extremity. This will be quantified in multiple questionnaires at baseline and three follow-up points, and by clinical evaluation of the hand function at baseline and two follow-up points. Study design: Single center prospective feasibility study
Interventions
PROCEDUREunilateral single-port VATS sympathicotomy
Sponsors
University of Groningen
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
Age 18 - 65 years. * ASA 1 en 2. * CRPS-1 defined according to IASP-Bruehl criteria at the wrist or lower arm level. 1. Continuing pain which is disproportionate to any inciting event 2. Must report at least one symptom in each of the four following categories * Sensory: reports of hyperesthesia * Vasomotor: reports of temperature asymmetry, skin color change or asymmetry. * Sudomotor/edema: reports of edema, sweating changes, sweating asymmetry * Motor/trophic: reports of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), trophic changes (hair, nail, skin) 3. Must display at least one sign in two or more of the following categories: * Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch) * Vasomotor: evidence of temperature asymmetry, color changes, asymmetry * Sudomotor/edema: evidence of edema, sweating changes, sweating asymmetry * Motor/trophic: evidence of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), trophic changes (hair, nail, skin)
Exclusion criteria
Known COPD \> Gold class 1. * History of smoking \> 20 pack years, due to higher risk of complications following unilateral lung- deflation and re-insufflation. * Documented substance addiction. * Previous intra-thoracic pleural drainage on affected side. * Previous thoracic surgery on affected side (including sternotomy). - Gross pulmonary or pleural abnormalities on chest X-ray. * Pregnancy, determined by preoperative pregnancy test. * Unsuitable anatomy (e.g. due to severe physical malformations).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in perceived pain measured in Visual Analogue Scale | Baseline, 1, 3 and 6 months postoperative |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in function in extremity | Baseline, 1 and 6 months after intervention | Strength in fingers, maximal flexion/extension in all digits, volumetric measurement, timing simple daily tasks. |
Countries
Netherlands
Outcome results
None listed